
In partnership with Dell Medical School’s Health Transformation Research Institute (HTRI), Texas Biologics aims to translate more biologic therapies to the clinic. Together, we are launching multiple programs.
Biologics Translational Science Studios
HTRI is connecting clinician investigators at Dell Med with scientists across the UT campus through a yearly studio program. This program provides a venue to facilitate translational collaboration to maximize the clinical applicability of laboratory-based developmental work.
Teams meet regularly to develop a research question and design translational studies to answer the question. Teams are then invited to submit proposals to an advisory panel for a translational study that proposes a line of inquiry. The proposals also describe collection of clinical data and biospecimens and complementary laboratory-based experiments. As investigator teams and their projects mature to the point that they are appropriate for Phase 1 trials and a pharmaceutical partner is engaged, the studios will transition to a forum to ensure that wet lab scientists are partners with clinician investigators in the design, execution, and interpretation of Phase 1 trial data.
2025 Science Studios Grants
Development of a Translational Platform for Evaluating Drug Safety in Breastfeeding
- Alison G. Cahill, M.D., M.S.C.I. (Professor, Department of Women's Health, Dell Medical School), and Aaron B. Baker, Ph.D. (Professor, Department of Biomedical Engineering)
Examining the Links between Clonal Hematopoiesis (CH) with Risks for Cardiovascular and Autoimmune Diseases
- Khang D. Nguyen, MD, MS. (Assistant Professor, Department of Internal Medicine (Dermatology), and Vagheesh Narasimhan, Ph.D. (Assistant Professor, Department of Integrative Biology and Department of Statistics & Data Sciences)
2024 Science Studios Grants
2023 Science Studios Grants
Clinical Trials Infrastructure
HTRI is expanding Dell Medical School's clinical trials infrastructure. HTRI brings together clinical research space and associated staffing and equipment, investigational pharmacy, and study coordinators so that all the infrastructure needed to navigate the regulatory process, recruit, enroll, and follow study participants is ready for clinical trial opportunities.